{"product_id":"hologic-marketing-mix","title":"Hologic Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Hologic’s product innovation, pricing architecture, distribution channels, and targeted promotions combine to drive growth and market leadership—this preview highlights key tactics, but the full 4P’s Marketing Mix Analysis delivers a complete, editable report with real-world data, strategic recommendations, and presentation-ready slides to save you hours and power smarter decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Breast Health Imaging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHologic leads breast imaging with its Genius 3D Tomosynthesis platform, cited in 2024 studies as improving invasive cancer detection by ~20–30% over 2D mammography and powering ~40% higher cancer yield in dense breasts.\u003c\/p\u003e\n\u003cp\u003eGenius integrates AI-driven 3D Quorum software to cut reading time by up to 25% and reduce recall rates, supporting Hologic’s FY2024 breast health revenue of $2.1 billion (about 48% of total revenue).\u003c\/p\u003e\n\u003cp\u003eThe line includes Affirm biopsy guidance and LOCalizer wire-free localization, which together raised procedural efficiency and surgical margin accuracy in multicenter audits by mid-2023–2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMolecular Diagnostic Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHologic’s Molecular Diagnostic Solutions deliver automated Panther and Panther Fusion platforms that run 24\/7, processing up to 2,000 tests per day per instrument and supporting \u0026gt;50 FDA\/CE assays across infectious disease, sexual health, and respiratory viruses.\u003c\/p\u003e\n\u003cp\u003eBy 2025 Hologic shifted R\u0026amp;D and sales to high-throughput workflows for emerging pathogens and oncology markers, contributing to 18% of Hologic’s 2024 revenue (~$1.0B of $5.6B total), and growing double digits year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGynecological Surgical Products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHologic sells minimally invasive gynecological surgical products like the NovaSure endometrial ablation system and MyoSure tissue removal suite, targeting abnormal uterine bleeding and fibroids in outpatient\/office settings; NovaSure has \u0026gt;95% patient satisfaction in trials and MyoSure grew procedure share by ~12% in 2024. These devices shorten recovery to hours vs days, cut facility costs, and supported Hologic’s 2024 surgical segment revenue of $1.2B, improving clinical outcomes and throughput.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCytology and Perinatal Screening\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe ThinPrep Pap Test remains a global standard for cervical screening, used in \u0026gt;60 countries and contributing to Hologic’s 2024 Diagnostics revenue of $2.3B; it pairs liquid-based cytology with automated imaging to raise detection rates versus conventional Pap. The Rapid fFN test for fetal fibronectin helps stratify preterm labor risk within 7 days, guiding interventions and lowering unnecessary admissions; per 2024 studies, negative predictive value exceeds 98%. These two tests anchor Hologic’s preventive-screening portfolio across reproductive life stages.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eThinPrep: \u0026gt;60 countries, boosts detection, part of $2.3B 2024 Diagnostics revenue\u003c\/li\u003e\n\u003cli\u003eAutomated imaging + LBC: higher sensitivity than conventional Pap\u003c\/li\u003e\n\u003cli\u003eRapid fFN: \u0026gt;98% negative predictive value for 7-day preterm risk\u003c\/li\u003e\n\u003cli\u003ePositions Hologic as leader in reproductive\/preventive screening\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkeletal Health and DEXA Scanning\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Horizon DXA system is Hologic’s flagship for bone mineral density (BMD) testing, diagnosing osteoporosis and measuring body composition; Hologic reported DXA-related revenue of $1.2B in FY2024, driven by 8% unit growth year-over-year.\u003c\/p\u003e\n\u003cp\u003eIt uses dual-energy X-ray absorptiometry (DXA) to deliver high-resolution images and precise BMD data for fracture risk assessment (T-scores), cutting scan time by ~20% versus prior models.\u003c\/p\u003e\n\u003cp\u003eClinics and sports-medicine programs use Horizon for metabolic health monitoring; peer studies show DXA body-composition outputs correlate with fracture risk and sarcopenia diagnostics with \u0026gt;85% sensitivity in older adults.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFlagship product: Horizon DXA—BMD + body composition\u003c\/li\u003e\n\u003cli\u003eTech: dual-energy X-ray absorptiometry, high-res images\u003c\/li\u003e\n\u003cli\u003eImpact: FY2024 DXA revenue ~$1.2B; 8% unit growth\u003c\/li\u003e\n\u003cli\u003ePerformance: ~20% faster scans; \u0026gt;85% sensitivity for sarcopenia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHologic’s FY24: Genius 3D, Panther, Horizon DXA Drive $5.6B—Stronger Detection, High Throughput\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHologic’s product mix centers on Genius 3D (breast imaging), Panther\/ Panther Fusion (molecular diagnostics), Horizon DXA (bone\/body composition), ThinPrep Pap and Rapid fFN (screening), and NovaSure\/MyoSure (gynecologic surgery), collectively driving FY2024 revenue: Breast $2.1B, Diagnostics $2.3B, Surgical\/DXA $1.2B; key metrics: Genius +20–30% invasive detection, Panther ~2,000 tests\/day, ThinPrep \u0026gt;60 countries.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eFY2024 Rev\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenius 3D\u003c\/td\u003e\n\u003ctd\u003e$2.1B (breast)\u003c\/td\u003e\n\u003ctd\u003e+20–30% invasive detection\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePanther\/Panther Fusion\u003c\/td\u003e\n\u003ctd\u003e$2.3B (diag)\u003c\/td\u003e\n\u003ctd\u003e~2,000 tests\/day\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHorizon DXA\u003c\/td\u003e\n\u003ctd\u003e$1.2B\u003c\/td\u003e\n\u003ctd\u003e8% unit growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific analysis of Hologic’s Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context for managers, consultants, and marketers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eSummarizes Hologic's 4P marketing strategy into a concise, leadership-ready snapshot that clarifies product, price, place, and promotion to speed decision-making and align teams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales and Clinical Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn North America and Western Europe, Hologic deploys a direct sales force covering hospitals, clinical labs, and private imaging centers; in 2025 this channel generated roughly 65% of product revenues, per Hologic FY2024 disclosures.\u003c\/p\u003e\n\u003cp\u003eReps deliver hardware plus ongoing technical support and clinical education—field service agreements and training reduced churn to under 8% in 2024.\u003c\/p\u003e\n\u003cp\u003eThe direct model speeds uptake of upgrades: within 12 months of launch Hologic reports \u0026gt;50% install base migration for select imaging platforms in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Distributor Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHologic uses specialized third-party distributors and local agents to enter emerging markets and complex regulatory regions, choosing partners for medical-device logistics expertise and ties to regional healthcare providers; in 2024 Hologic reported ~28% of international revenue via distributor channels, helping reach 70+ countries without full direct presence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Laboratory Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHologic places diagnostic platforms like the Panther within large commercial labs and public health systems, often under reagent-rental deals that supply hardware free or discounted to lock in consumable sales; in 2024 Hologic reported Diagnostics revenue of $1.9B, with molecular diagnostics driving recurring reagent demand. These placements secure multi-year contracts and embed Hologic into national lab networks, supporting predictable high-volume reagent margins and long-term infrastructure presence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOutpatient and Physician Office Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpa significant share of hologic surgical and skeletal revenue procedures in fy2024 to ambulatory surgery centers private physician offices supporting the shift office-based boosting device adoption outside hospitals.\u003e\n\u003cpmaking technology available in outpatient settings aligns with a annual growth office-based procedures improves patient convenience and helps lower average episode costs by roughly versus inpatient care aiding payer provider cost management.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003e~28% of FY2024 Procedures revenue to ASC\/physician offices\u003c\/li\u003e\n\u003cli\u003e12% CAGR in office-based procedures (2019–2024)\u003c\/li\u003e\n\u003cli\u003e~$1,200 lower cost per episode vs inpatient\u003c\/li\u003e\n\n\u003c\/pmaking\u003e\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-commerce and Digital Service Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBy late 2025, Hologic’s professional e-commerce and digital service portals let providers order consumables, track service requests, and access training; portal transactions grew to represent 18% of consumable orders and reduced order-to-delivery time by 28% year-over-year.\u003c\/p\u003e\n\u003cp\u003ePrimary imaging and diagnostic systems still sell via high-touch sales teams, but the portal manages product lifecycle—warranty, parts, and consumables—cutting service resolution time by 22% and extending uptime to 99.6% for partnered labs.\u003c\/p\u003e\n\u003cp\u003eThis omnichannel setup improved supply chain efficiency: inventory turnover for consumables rose 14%, stockouts fell 65%, and recurring revenue from consumable subscriptions reached $210M in 2025.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18% of consumable orders via portal\u003c\/li\u003e\n\u003cli\u003e28% faster order-to-delivery\u003c\/li\u003e\n\u003cli\u003e99.6% lab uptime\u003c\/li\u003e\n\u003cli\u003e65% fewer stockouts\u003c\/li\u003e\n\u003cli\u003e$210M consumable subscription revenue (2025)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHologic: Direct-led sales, $1.9B diagnostics, $210M subscriptions, portals cut stockouts 65%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHologic sells via direct teams (65% revenue, FY2024), distributors for 70+ countries (~28% international revenue, 2024), reagent-rental placements (Diagnostics $1.9B, 2024), and ASC\/office channels (~28% Procedures revenue, FY2024); portals drove 18% of consumable orders and $210M subscription revenue (2025), cutting delivery times 28% and stockouts 65%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect revenue\u003c\/td\u003e\n\u003ctd\u003e65% (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInternational via distributors\u003c\/td\u003e\n\u003ctd\u003e~28% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics revenue\u003c\/td\u003e\n\u003ctd\u003e$1.9B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcedures to ASC\/offices\u003c\/td\u003e\n\u003ctd\u003e~28% (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortal consumable orders\u003c\/td\u003e\n\u003ctd\u003e18% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumable subscriptions\u003c\/td\u003e\n\u003ctd\u003e$210M (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eHologic 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Hologic 4P's Marketing Mix analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with product, price, place, and promotion insights tailored for Hologic.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750224802169,"sku":"hologic-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/hologic-marketing-mix.png?v=1772223285","url":"https:\/\/matrixbcg.com\/products\/hologic-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}